150 related articles for article (PubMed ID: 38671491)
1. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
Chen Y; Qiu X; Liu R
BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
[TBL] [Abstract][Full Text] [Related]
2. Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death.
Sheng X; Lu J; Wang J; Fan K; Huang M; Lu Q
Expert Rev Hematol; 2023; 16(7):543-551. PubMed ID: 37114857
[TBL] [Abstract][Full Text] [Related]
3. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
[TBL] [Abstract][Full Text] [Related]
4. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
[TBL] [Abstract][Full Text] [Related]
5. Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.
Li X; Zhang D; Guo P; Ma S; Gao S; Li S; Yuan Y
Aging (Albany NY); 2024 Apr; 16(7):6290-6313. PubMed ID: 38575204
[TBL] [Abstract][Full Text] [Related]
6. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
[TBL] [Abstract][Full Text] [Related]
8. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
[TBL] [Abstract][Full Text] [Related]
9. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
Chen L; Lin J; Wen Y; Chen Y; Chen CB
Front Oncol; 2023; 13():1291720. PubMed ID: 38023241
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.
Fu D; Zhang B; Wu S; Feng J; Jiang H
Front Cell Dev Biol; 2023; 11():1207642. PubMed ID: 37691822
[TBL] [Abstract][Full Text] [Related]
12. Definition of a Novel Immunogenic Cell Death-Relevant Gene Signature Associated with Immune Landscape in Gastric Cancer.
Meng Y; Jin Z; Wang M; Chen D; Zhu M; Huang Y; Xia S; Xiong Z
Biochem Genet; 2023 Oct; 61(5):2092-2115. PubMed ID: 36943521
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.
Ren J; Yang J; Na S; Wang Y; Zhang L; Wang J; Liu J
Front Immunol; 2022; 13():998653. PubMed ID: 36211436
[TBL] [Abstract][Full Text] [Related]
14. Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma.
Li Q; Tang Y; Wang T; Zhu J; Zhou Y; Shi J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):307-323. PubMed ID: 36575346
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
[TBL] [Abstract][Full Text] [Related]
17. A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia.
Zhong F; He S; Guo N; Shi L; Zhang L; Jin H; Kong G
Cancer Cell Int; 2024 Apr; 24(1):139. PubMed ID: 38627685
[TBL] [Abstract][Full Text] [Related]
18. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
20. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]